Shubhra Jain

Shubhra Jain, MD, MBA, serves as the Head of Healthcare Investments at Tarsadia Investments since 2022, focusing on venture and growth investments in health and biotechnology. Current involvement includes serving on the board of Matterworks and positions as an investor in Berkeley Lights, Inc. and Zymergen. Additionally, Shubhra Jain is a mentor within the Global Mentor program at Endeavor, an advisor for the Digital Health Council at Springboard Enterprises, and a board member of FemTech Collective, all aimed at supporting innovations in health technology and entrepreneurship. Shubhra Jain previously held a role as Principal at Cota Capital and has served on the boards of Mission Bio and Bioniz Therapeutics. Educational qualifications include an MBA from The Wharton School and INSEAD, an MS in Mechanical Engineering from Stanford University, and an MBBS from Kasturba Medical College, Manipal.